therapeutic issues
Last edited 07/2018
The following issues should be considered:
- when to start interferon therapy?
- interferon does not reverse disability which argues for early intervention, however
- 10-20% of patients with MS have a benign course and would not benefit from interferon treatment
- perhaps early treatment should be considered in patients with a poor prognosis
prognostic factors in multiple sclerosis
NICE guidance - beta interferon for the treatment of multiple sclerosis